Intracameral Enoxaparin for Descemet Membrane Endothelial Keratoplasty: A Pilot Safety Study
Enoxaparin can safely be used in DMEK surgery without apparent increased risk of intraoperative hemorrhage, graft detachment/failure, or endothelial cell toxicity.
Authors
- Lakshman Mulpuri (ORCID: https://orcid.org/0000-0003-4575-9136)
- Alfonso L. Sabater (ORCID: https://orcid.org/0000-0001-6383-2558)
- Albert Y. Cheung (ORCID: https://orcid.org/0000-0001-5546-6017)
- Kamran M. Riaz (ORCID: https://orcid.org/0000-0003-1090-5025)
- Evan J. Warner (ORCID: https://orcid.org/0000-0001-8728-3434)
- Dean P. Ouano (ORCID: https://orcid.org/0000-0002-4409-5246)
- Neal Rangu
- Rahul Tonk (ORCID: https://orcid.org/0000-0002-7761-0048)
- Angela C. Gomez (ORCID: https://orcid.org/0000-0001-7019-9607)
- Donald U. Stone
Institutions
- University of Wisconsin–Madison (US)
- Dean McGee Eye Institute (US)
- Rockwood Clinic (US)
- Virginia Eye Consultants (US)
- Cook County Health and Hospitals System (US)
- University of Oklahoma (US)
Publication Details
- Journal
- Cornea
- Published
- 2024-08-08
- DOI
- https://doi.org/10.1097/ico.0000000000003662
- Citations
- 4
- Primary Topic
- Corneal surgery and disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.62
Funders
- Research to Prevent Blindness